Neogen Corporation Allowance for Doubtful Accounts Receivable, Charge-offs (Deprecated 2013-01-31)
Neogen Corporation (NEOG) reported Allowance for Doubtful Accounts Receivable, Charge-offs (Deprecated 2013-01-31) of $38.00 thousand for the 12-month period ending 2012-05-31, per its 10-K filed 2012-07-30.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableChargeOffs · last filed 2012-07-30
- Neogen Corporation allowance for doubtful accounts receivable, charge-offs (deprecated 2013-01-31) for fiscal 2012 was $38.00K, a 83.48% decline from fiscal 2011.
- Neogen Corporation allowance for doubtful accounts receivable, charge-offs (deprecated 2013-01-31) for fiscal 2011 was $230.00K, a 4.96% decline from fiscal 2010.
- Neogen Corporation allowance for doubtful accounts receivable, charge-offs (deprecated 2013-01-31) for fiscal 2010 was $242.00K.
| Period end | Allowance for Doubtful Accounts Receivable, Charge-offs (Deprecated 2013-01-31) 12 month |
|---|---|
| 2012-05-31 | $38.00K 10-K · filed 2012-07-30 |
| 2011-05-31 | $230.00K 10-K · filed 2012-07-30 |
| 2010-05-31 | $242.00K 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |